Oliver Billker joined MIMS as Director in October 2018. He was previously a senior group leader at the Wellcome Trust Sanger Institute and one of the lead investigators for their PlasmoGEM Malaria Programme project. Here, he tells us a bit more about his research, and what he hopes to achieve in his time at Umeå. Billker also holds a professorship at the Department of Molecular Biology, Umeå University.